Michael Rowley
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Virology top 2%
- HIV Research and Treatment
Papers in ⓘ
- Hepatology 28
- Hepatitis C virus research 23
- Virology 10
- Co-authors
- Philip Jones (24 shared papers)Sergio Altamura (13 shared papers)Paul D. Leeson (21 shared papers)Yoshito Kishi (2 shared papers)Carlo Toniatti (8 shared papers)Frank Narjes (15 shared papers)Raffaele De Francesco (9 shared papers)Edith Monteagudo (17 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (35 papers)Journal of Medicinal Chemistry (21 papers)Tetrahedron Letters (6 papers)Tetrahedron (4 papers)Bioorganic & Medicinal Chemistry (4 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Michael Rowley
115 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 118
- Hepatology 598
- Virology 290
- Organic Chemistry 1.6k
- Infectious Diseases 706
- Molecular Biology 1.7k
Countries citing papers authored by Michael Rowley
This map shows the geographic impact of Michael Rowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rowley more than expected).
Fields of papers citing papers by Michael Rowley
This network shows the impact of papers produced by Michael Rowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rowley. The network helps show where Michael Rowley may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Rowley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 255 | |
| 2 | 2003 | 160 | |
| 3 | 2005 | 135 | |
| 4 | 2015 | 129 | |
| 5 | 1989 | 115 | |
| 6 | 2001 | 103 | |
| 7 | 1997 | 103 | |
| 8 | 1996 | 94 | |
| 9 | 2002 | 93 | |
| 10 | 2001 | 93 | |
| 11 | Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. | 1999 | 89 |
| 12 | 1993 | 81 | |
| 13 | 2008 | 81 | |
| 14 | 2006 | 74 | |
| 15 | 2006 | 72 | |
| 16 | 2005 | 69 | |
| 17 | 1989 | 67 | |
| 18 | 2005 | 63 | |
| 19 | 1996 | 63 | |
| 20 | 2007 | 58 |
About Michael Rowley
Michael Rowley is a scholar working on Hepatology, Virology, Infectious Diseases, Molecular Biology and Organic Chemistry, having authored 120 papers that have together received 4.0k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (29 papers), Hepatitis C virus research (23 papers), Neuroscience and Neuropharmacology Research (14 papers), Hepatitis B Virus Studies (13 papers), Chemical Synthesis and Analysis (12 papers), Histone Deacetylase Inhibitors Research (11 papers), Biochemical and Molecular Research (11 papers) and Protein Degradation and Inhibitors (10 papers). The work is most often cited by research in Hepatology (598 citations), Virology (290 citations), Organic Chemistry (1.6k citations), Infectious Diseases (706 citations) and Molecular Biology (1.7k citations). Michael Rowley has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Philip Jones, Sergio Altamura, Paul D. Leeson, Yoshito Kishi, Carlo Toniatti, Frank Narjes, Raffaele De Francesco, Edith Monteagudo, Jesus M. Ontoria and Christian Steinkühler. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Tetrahedron Letters, Tetrahedron and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.